Ranispas DV 40mg/150mg Tablet
By Ranispas DV
Rx
10 Tablet in a Strip

Composition
Drotaverine(40mg) + Ranitidine(150mg)

Manufacturer - Mankind Pharma Ltd
208, Okhla Industrial Estate, Phase III, New Delhi - 110020

Expires on or after
September, 2025

liver
When using Ranispas DV 40mg/150mg Tablet, it is important to exercise caution if you have liver disease. Patients with liver issues may require a dose adjustment while taking Ranispas DV 40mg/150mg Tablet. It is advisable to consult your doctor before starting this medication to ensure it is safe for you.

kidney
Ranispas DV 40mg/150mg Tablet requires caution in patients with kidney disease. Dose adjustment may be necessary, so it's important to consult your doctor regarding its use.

alcohol
It is unsafe to drink alcohol while taking Ranispas DV 40mg/150mg Tablet. Avoid mixing alcohol with this medication to prevent any potential risks or harmful effects.

driving
Ranispas DV 40mg/150mg Tablet may cause side effects that could impact your driving ability due to possible vertigo.

pregnancy
Information on the safety of Ranispas DV 40mg/150mg Tablet during pregnancy is not available. It is advisable to consult with your doctor before using this medication.

breastfeeding
It is better to consult your doctor before using Ranispas DV 40mg/150mg Tablet during breastfeeding as information on its safety is unavailable.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | - |
₹40.33
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025